Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mahanna Vanzeler Vaz
Institution:
Instituto Nacional de Câncer - INCA
Observed institution:
Instituto Nacional de Câncer - INCA
ORCID:
0000-0002-9515-8817
Observed ORCID:
0000-0002-9515-8817
OpenAlex ID:
A5013481825
Management of chemotherapy-induced febrile neutropenia and use of granulocyte colony-stimulating factor in patients with soft tissue or bone sarcoma
2022
·
Raphaele Teixeira Mazzaro
, Mahanna Vanzeler Vaz
, et al.
·
Journal of Oncology Pharmacy Practice
·
4
Adequacy of a Questionnaire for Evaluation of Radiopharmaceuticals-related Adverse Events: Cross-cultural Adaptation
2026
·
Maria Carolina Peçanha Fernandes
, Mahanna Vanzeler Vaz
, et al.
·
Revista Brasileira de Cancerologia
Adecuación del Cuestionario para la Evaluación de Eventos Adversos Relacionados con los Radiofármacos: Adaptación Transcultural
2026
·
Maria Carolina Peçanha Fernandes
, Mahanna Vanzeler Vaz
, et al.
·
Revista Brasileira de Cancerologia
Real-World Effectiveness, Safety, and Adverse Event Kinetics of Pembrolizumab in Advanced Melanoma within the Brazilian Public Health System
2026
·
Hildeneide Rocha Lima
, Mahanna Vanzeler Vaz
, et al.
·
Journal of Oncology Pharmacy Practice
Show more works
View as search
Works count:
4
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type